BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsutsumi Y, Yamamoto Y, Ito S, Ohigashi H, Shiratori S, Naruse H, Teshima T. Hepatitis B virus reactivation with a rituximab-containing regimen. World J Hepatol 2015; 7(21): 2344-2351 [PMID: 26413224 DOI: 10.4254/wjh.v7.i21.2344]
URL: https://www.wjgnet.com/1948-5182/full/v7/i21/2344.htm
Number Citing Articles
1
Louis-Bassett Porter, Elena Kozakewich, Ryan Clouser, Colleen Kershaw, Andrew J. Hale. Occam’s razor need not apply: Advanced HIV infection presenting with five simultaneous opportunistic infections and central nervous system lymphomaIDCases 2018; 13: e00437 doi: 10.1016/j.idcr.2018.e00437
2
Funda PEPEDİL TANRİKULU, Didar YANARDAĞ AÇIK, Bilal AYGUN, Mehmet BANKİR, Mikail ÖZDEMİR. The compliance of our practice of hepatitis B virus screening with the current guidelines in patients undergoing chemotherapy for hematological malignanciesJournal of Surgery and Medicine 2021; 5(11): 1095 doi: 10.28982/josam.981625
3
Takuhiro Shoji, Masayuki Kanamori, Jun Inoue, Ryuta Saito, Yoshinari Osada, Yoshiteru Shimoda, Masashi Chonan, Hiroshi Uenohara, Atsushi Masamune, Teiji Tominaga. Hepatitis B virus reactivation during temozolomide administration for malignant gliomaInternational Journal of Clinical Oncology 2021; 26(2): 305 doi: 10.1007/s10147-020-01814-7
4
R.N. Makroo, Soma Agrawal, Mohit Chowdhry, Brinda Kakkar, Uday K. Thakur. Efficacy of single, extended and goal directed immunoadsorption in ABO incompatible living related donor liver transplantationTransfusion and Apheresis Science 2016; 55(3): 329 doi: 10.1016/j.transci.2016.08.007
5
Katsuki Sugiyama. Chemotherapy for Leukemia2017; : 79 doi: 10.1007/978-981-10-3332-2_5
6
Bertram Bengsch, Kyong-Mi Chang. Evolution in Our Understanding of Hepatitis B Virus Virology and ImmunologyClinics in Liver Disease 2016; 20(4): 629 doi: 10.1016/j.cld.2016.06.001
7
Michał Witkowski, Magdalena Witkowska, Tadeusz Robak. Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugsEuropean Journal of Haematology 2019; 103(6): 531 doi: 10.1111/ejh.13319
8
Tetsuya Akaishi, Ichiro Nakashima. Efficiency of antibody therapy in demyelinating diseasesInternational Immunology 2017; 29(7): 327 doi: 10.1093/intimm/dxx037
9
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, Carsten Utoft Niemann. Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet NeedsActa Haematologica 2024; 147(1): 84 doi: 10.1159/000533234
10
Timothy M. Block, Kyong-Mi Chang, Ju-Tao Guo. Prospects for the Global Elimination of Hepatitis BAnnual Review of Virology 2021; 8(1): 437 doi: 10.1146/annurev-virology-091919-062728
11
Praopilad Srisuwarn, Vasant Sumethkul. Kidney transplant from donors with hepatitis B: A challenging treatment optionWorld Journal of Hepatology 2021; 13(8): 853-867 doi: 10.4254/wjh.v13.i8.853
12
Sophia Ly, Dmitry Nedosekin, Henry K. Wong. Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the SkinAmerican Journal of Clinical Dermatology 2023; 24(2): 247 doi: 10.1007/s40257-022-00751-7
13
Luis Malpica, David van Duin, Stephan Moll. Preventing infectious complications when treating non‐malignant immune‐mediated hematologic disordersAmerican Journal of Hematology 2019; 94(12): 1396 doi: 10.1002/ajh.25642
14
Hyun Mi Kwon, Kichul Shin, Jin Young Moon, Shin-Seok Lee, Won Tae Chung, Jisoo Lee, Sang-Heon Lee, Seong-Wook Kang, Chang Hee Suh, Seung-Jae Hong, Ran Song, Jung-Yoon Choe, Yeong Wook Song. Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic TherapyJournal of Rheumatic Diseases 2018; 25(2): 108 doi: 10.4078/jrd.2018.25.2.108
15
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatmentsExpert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
16
Chrong-Reen Wang, Hung-Wen Tsai. Human hepatitis viruses-associated cutaneous and systemic vasculitisWorld Journal of Gastroenterology 2021; 27(1): 19-36 doi: 10.3748/wjg.v27.i1.19
17
Cesare Mazzaro, Riccardo Bomben, Marcella Visentini, Laura Gragnani, Luca Quartuccio, Francesco Saccardo, Marco Sebastiani, Davide Filippini, Gianfranco Lauletta, Giuseppe Monti, Valter Gattei. Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literatureFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1095780
18
Daryl R Cheng, Rebecca Barton, Anthea Greenway, Nigel W Crawford. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patientsExpert Review of Vaccines 2016; 15(12): 1567 doi: 10.1080/14760584.2016.1193438
19
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for LymphomaAnnals of Hepatology 2017; 16(2): 198 doi: 10.5604/16652681.1231579
20
Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapyBlood 2019; 133(2): 137 doi: 10.1182/blood-2018-04-848044
21
Daisuke Ueki, Shinya Suzuki, Takahiro Ohta, Akira Shinohara, Yasukata Ohashi, Daisuke Konuma, Yasuaki Ryushima, Ryoko Udagawa, Hironori Motoshige, Masahiro Ieoka, Akihiro Taji, Yuuki Kogure, Mikako Hiraike, Miyuki Uoi, Kazuhiko Ino, Toshikatsu Kawasaki, Masakazu Yamaguchi. Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective SurveyPharmacy 2023; 12(1): 1 doi: 10.3390/pharmacy12010001
22
Prowpanga Udompap, W. Ray Kim. Hepatitis B Virus and Liver Disease2021; : 427 doi: 10.1007/978-981-16-3615-8_18
23
Xiao Yan, Miao Zhou, Zhongze Lou, Qitian Mu, Lixia Sheng, Ping Zhang, Yi Wang, Guifang Ouyang. Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera eraJournal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S248 doi: 10.4103/0973-1482.187285
24
Chunmei Yang, Mixue Xie, Kaifeng Zhang, Hui Liu, Aibin Liang, Ken H. Young, Wenbin Qian. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infectionLeukemia 2020; 34(11): 3055 doi: 10.1038/s41375-020-0913-y
25
Ai Kubodera, Ayaka Kume, Kiyohito Hayashi, Ryo Shimizu, Akihiro Miyakawa, Yoshihiro Miyauchi, Yoshio Suzuki, Hiroaki Tanaka. Immune Thrombocytopenic Purpura Complicated by Hepatitis C Virus-related Membranoproliferative Glomerulonephritis after Rituximab TherapyInternal Medicine 2021; 60(15): 2469 doi: 10.2169/internalmedicine.6758-20
26
Jingjing Wang, Xin Zhang, Xiaozhen Geng, Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang, Wenjun Wang. Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databaseseClinicalMedicine 2022; 48: 101425 doi: 10.1016/j.eclinm.2022.101425
27
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard TherapiesCurrent Hepatology Reports 2018; 17(3): 166 doi: 10.1007/s11901-018-0401-2
28
Dae San Yoo, Jong Hoon Kim, Soo-Chan Kim. Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximabJAAD Case Reports 2020; 6(2): 83 doi: 10.1016/j.jdcr.2019.10.017
29
Katharina Boden, Sabine Lobenstein, Beate Hermann, Gabriele Margos, Volker Fingerle. Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised PersonEmerging Infectious Diseases 2016; 22(9): 1617 doi: 10.3201/eid2209.152034
30
Denise Yeo, Ihtimam Hossain, Soon Thye Lim, Mohamad Farid, Miriam Tao, Richard Quek, Tiffany Tang, Alexandre Chan. Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational studyJournal of Oncology Pharmacy Practice 2019; 25(5): 1042 doi: 10.1177/1078155218763039
31
Esma Bilajac, Lejla Mahmutović, Kenneth Lundstrom, Una Glamočlija, Jasmin Šutković, Abas Sezer, Altijana Hromić-Jahjefendić. Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma TumorigenesisViruses 2022; 14(10): 2105 doi: 10.3390/v14102105
32
Timothy P.W. Jones, Matthew Buckland, Judith Breuer, David M. Lowe. Viral infection in primary antibody deficiency syndromesReviews in Medical Virology 2019; 29(4) doi: 10.1002/rmv.2049
33
Sama Anvari, Keith Tsoi. Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?Journal of Clinical Medicine 2024; 13(2): 393 doi: 10.3390/jcm13020393
34
Michael Kriss, Matthew Burchill. HCV and nonhepatic malignancy: Is pre‐emptive direct‐acting antiviral therapy indicated prior to treatment?Hepatology 2018; 67(1): 4 doi: 10.1002/hep.29414
35
Natasha Dubois Cauwelaert, Susan L. Baldwin, Mark T. Orr, Anthony L. Desbien, Emily Gage, Kimberly A. Hofmeyer, Rhea N. Coler. Antigen presentation by B cells guides programing of memory CD4+ T‐cell responses to a TLR4‐agonist containing vaccine in miceEuropean Journal of Immunology 2016; 46(12): 2719 doi: 10.1002/eji.201646399
36
Connor Prosty, Khaled Katergi, Alex Nguyen, Owen Dan Luo, Mark Sorin, Vladimir Cherniak, Michael Sebag, Koray Demir, Emily G. McDonald, Todd C. Lee, Matthew P. Cheng. Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTsBlood Advances 2024; 8(4): 857 doi: 10.1182/bloodadvances.2023011964
37
Saket Jhajharia, Fritz Lai, Heng Boon Low, Kiren Purushotorman, Bhuvaneshwari D/O Shunmuganathan, Conrad En Zuo Chan, Rachel Hammond, Hans-Jürgen Netter, Qingfeng Chen, Seng Gee Lim, Paul A. MacAry. Defining the specificity and function of a human neutralizing antibody for Hepatitis B virusnpj Vaccines 2022; 7(1) doi: 10.1038/s41541-022-00516-7
38
Christopher Hahn, Adrian Budhram, Katayoun Alikhani, Nasser AlOhaly, Grayson Beecher, Gregg Blevins, John Brooks, Robert Carruthers, Jacynthe Comtois, Juthaporn Cowan, Paula de Robles, Julien Hébert, Ronak K. Kapadia, Sarah Lapointe, Aaron Mackie, Warren Mason, Brienne McLane, Alexandra Muccilli, Ilia Poliakov, Penelope Smyth, Kimberly G. Williams, Christopher Uy, Jennifer A. McCombe. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2024; : 1 doi: 10.1017/cjn.2024.16
39
Bernd Lorenz Hartmann, Michèle Desiré Atzl. HIV-triggered lymphomamemo - Magazine of European Medical Oncology 2019; 12(3): 230 doi: 10.1007/s12254-019-00518-7
40
Wenli Zhu, Yaling Zhang, Zhen Wang, Ying Fu, Yaping Yan. Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to BedsideNeuroscience Bulletin 2020; 36(10): 1213 doi: 10.1007/s12264-020-00525-3
41
Jia Wei, Xiaojian Zhu, Xia Mao, Liang Huang, Fankai Meng, Jianfeng Zhou. Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphomaJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0790-y
42
Young Chang, Soung Won Jeong, Jae Young Jang. Hepatitis B Virus Reactivation Associated With Therapeutic InterventionsFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770124
43
Ping Li, Lili Zhou, Shiguang Ye, Wenjun Zhang, Junbang Wang, Xiaochen Tang, Jie Liu, Yangyang Xu, Wenbin Qian, Aibin Liang. Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral ProphylaxisFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.638678
44
Violeta Molagic, Cristina Popescu, Catalin Tiliscan, Victoria Arama, Stefan Sorin Arama. Rapid loss of HBs antigen in patients with HBV reactivation and high level of transaminases during immunosuppressive therapy - case seriesRevista Romana de Medicina de Laborator 2021; 29(1): 105 doi: 10.2478/rrlm-2020-0039
45
G. Azizi, V. Ziaee, M. Tavakol, T. Alinia, R. Yazdai, H. Mohammadi, H. Abolhassani, A. Aghamohammadi. Approach to the Management of Autoimmunity in Primary ImmunodeficiencyScandinavian Journal of Immunology 2017; 85(1): 13 doi: 10.1111/sji.12506
46
Young Chang. Jaundice That Has Persisted for 5 Days The Korean Journal of Medicine 2024; 99(3): 140 doi: 10.3904/kjm.2024.99.3.140
47
Prowpanga Udompap, W. Ray Kim. Hepatitis B Virus and Liver Disease2018; : 315 doi: 10.1007/978-981-10-4843-2_16
48
Daniel Sedhom, Melroy D’Souza, Elizabeth John, Vinod Rustgi. Viral Hepatitis and Acute Liver FailureClinics in Liver Disease 2018; 22(2): 289 doi: 10.1016/j.cld.2018.01.005
49
Alison Jee, Samantha Christine Sernoskie, Jack Uetrecht. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical ChallengesInternational Journal of Molecular Sciences 2021; 22(6): 2954 doi: 10.3390/ijms22062954
50
Connor Cole, Kyle Amber. Pemphigus for the Inpatient DermatologistCurrent Dermatology Reports 2022; 11(4): 221 doi: 10.1007/s13671-022-00369-2
51
Arshi Khanam, Joel V. Chua, Shyam Kottilil. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionInternational Journal of Molecular Sciences 2021; 22(11): 5497 doi: 10.3390/ijms22115497
52
Jacky C. L. Ho, Joyce W. Y. Mak, Terry C. F. Yip, Hong Man Lam, Tsz Yan Cheng, Tsz On Lam, Lai Shan Tam, Man Fai Law, Carmen K. M. Cheung, Siew C. Ng, Vincent W. S. Wong, Grace L. H. Wong. Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based studyLiver International 2023; 43(3): 588 doi: 10.1111/liv.15499
53
N. Blank, H.-M. Lorenz. Kryoglobulinämische VaskulitidenZeitschrift für Rheumatologie 2016; 75(3): 303 doi: 10.1007/s00393-016-0076-4
54
Sirina Ekpanyapong, K. Rajender Reddy. Hepatitis B Virus ReactivationClinics in Liver Disease 2020; 24(3): 317 doi: 10.1016/j.cld.2020.04.002
55
Kilian Bock, Heiner Wedemeyer, Young-Seon Mederacke, Ingmar Mederacke. Elevated liver enzymes in a German tertiary-care hospital: Distribution, diagnostic steps and diagnosis groupsZeitschrift für Gastroenterologie 2024; 62(06): 919 doi: 10.1055/a-2150-2077
56
Kentaro Sato, Hidemichi Imamura, Yu Watahiki, Hiromasa Hazama, Takeaki Hashimoto, Shinji Mukae, Hiromasa Ohhira. A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell LymphomaInternal Medicine 2023; 62(11): 1611 doi: 10.2169/internalmedicine.0420-22
57
Guilherme Diogo Silva, Vítor Falcão de Oliveira, Leonardo Oliveira Mendonça. Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based reviewArquivos de Neuro-Psiquiatria 2022; 80(5 suppl 1): 173 doi: 10.1590/0004-282x-anp-2022-s121
58
Martin Feuchtenberger, Arne Schäfer, Axel Philipp Nigg, Michael Rupert Kraus. Hepatitis B Serology in Patients with Rheumatic DiseasesThe Open Rheumatology Journal 2016; 10(1): 39 doi: 10.2174/1874312901610010039
59
Prajjwol Luitel, Anup Ghimire, Devansh Upadhyay, Rajeev Ojha. Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysisClinical and Experimental Neuroimmunology 2022; 13(4): 194 doi: 10.1111/cen3.12695